ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

Kansas City Clinic Settles Medicare Overbilling Claim

June 6, 2014

What Should NCI Do When Center Directors Leave? Kimes Asks

July 24, 1992

Genentech’s Ferrara Wins Lasker Award For VEGF Discovery

October 8, 2010

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

February 11, 2011

In Brief: Senate Subcommittee Includes $2.7 Billion Increase for NIH in Budget Bill Markup

May 12, 2000

In Brief: Durant Says He Expects Comprehensive Centers Lineup to Change With New System

December 15, 1989